ACTIVE SUBSTANCE / INN

LONAFARNIB

Brand name(s): ZOKINVY, Zokinvy
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA213969
Progeria;Laminopathies
ACTIVE SUBSTANCE
Lonafarnib
REGULATORS
FDA · EMA
SPONSORS / MAH
SENTYNL THERAPS INC, TMC Pharma (EU) Limited
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ZOKINVYNDA213969SENTYNL THERAPS INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ZokinvyTMC Pharma (EU) LimitedAuthorised18/07/2022Progeria;Laminopathies

FULL INTELLIGENCE ON LONAFARNIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →